SCHEMBL235343

SCHEMBL235343

[C]1=C(C2CCCCC2)CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7685464 1.00
SCHEMBL16703986 1.00
SCHEMBL5699291 1.00
SCHEMBL7111854 1.00
SCHEMBL3419762 0.98
SCHEMBL9258454 0.93
SCHEMBL4239484 0.90
SCHEMBL8366251 0.90
SCHEMBL1780079 0.87
SCHEMBL6058335 0.85

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 476 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648862-A2 SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION Achillion Pharmaceuticals, Inc. (US) 2006-04-26 EP claimed
WO-2005007601-A2 SUBSTITUTED ARYLTHIOUREA DERIVATIVES USEFUL AS INHIBITORS OF VIRAL REPLICATION ACHILLION PHARMACEUTICALS, INC. (US) 2005-01-27 WO claimed
US-4017627-A 7,8-Disubstituted-5-acetylquinolines and antimicrobial compositions containing them CIBA-GEIGY CORPORATION (US) 1977-04-12 US claimed
CN-118355029-A Methods of treating diffuse large B-cell lymphomas using anti-CD 79B immunoconjugates 基因泰克公司 2024-07-16 CN disclosed
CN-112689634-B SMAD3 inhibitors 莫扎制药有限公司 2024-07-16 CN disclosed
US-20240226342-A1 REACTIVE OXYGEN SPECIES IMAGING AGENTS WASHINGTON UNIVERSITY (US) 2024-07-11 US disclosed
US-12016842-B2 Methods of using anti-CD79b immunoconjugates GENENTECH, INC. (US) 2024-06-25 US disclosed
CN-118215676-A Specific conjugation of antibody drug conjugates 杭州多禧生物科技有限公司 2024-06-18 CN disclosed
EP-4380978-A1 METHODS OF USING ANTI-CD79B IMMUNOCONJUGATES TO TREAT DIFFUSE LARGE B-CELL LYMPHOMA Genentech, Inc. (US) 2024-06-12 EP disclosed
US-11998584-B2 Conjugate of a tubulysin analog with branched linkers HANGZHOU DAC BIOTECH CO., LTD. (CN) 2024-06-04 US disclosed
US-20240179825-A1 SYSTEMS AND METHODS FOR NONEQUILIBRIUM PLASMAS WASHINGTON UNIVERSITY 2024-05-30 US disclosed
WO-1999065908-A1 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS PFIZER PRODUCTS INC. (US) 1999-12-23 WO disclosed
US-5585036-A Liquid crystal compounds containing chiral 2-halo-2-methyl ether and ester tails DISPLAYTECH, INC. (US) 1996-12-17 US disclosed
EP-0549068-B1 Alkyl peroxides and uses DSM NV (NL) 1996-02-21 EP disclosed
EP-0549068-A1 Alkyl peroxides and uses DSM N.V. (NL) 1993-06-30 EP disclosed
US-4820853-A Process for the preparation of alkyl diaryl phosphites and diaryl halophosphates AKZO AMERICA INC. (US) 1989-04-11 US disclosed
EP-0102230-B1 NOVEL 6-NITROPROSTAGLANDIN DERIVATIVES, PROCESS FOR PRODUCTION THEREOF, AND USE THEREOF TEIJIN LIMITED (JP) 1987-04-29 EP disclosed
US-4060639-A Broad spectrum antibacterial compositions containing tris-(hydroxymethyl)-aminoethane and dicycloaliphatic-alkyl polyamines MERCK & CO., INC. (US) 1977-11-29 US disclosed
US-4049417-A CONTAINING CYCLOHEXYL OR CYCLOHEXENYL RINGS MERCK & CO., INC. (US) 1977-09-20 US disclosed
US-3965220-A AMINE CATALYST MONSANTO COMPANY (US) 1976-06-22 US disclosed